EW
NYSE · Health Care
Edwards Lifesciences Corp
$88.78
+0.44 (+0.50%)
Financial Highlights (FY 2026)
Revenue
5.97B
Net Income
1.06B
Gross Margin
78.0%
Profit Margin
17.7%
Rev Growth
+4.1%
D/E Ratio
0.06
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 78.0% | 78.0% | 59.8% | 59.8% |
| Operating Margin | 18.4% | 16.6% | 16.8% | 18.7% |
| Profit Margin | 17.7% | 16.8% | 12.8% | 13.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.97B | 5.74B | 13.78B | 12.17B |
| Gross Profit | 4.66B | 4.47B | 8.23B | 7.27B |
| Operating Income | 1.10B | 950.32M | 2.31B | 2.28B |
| Net Income | 1.06B | 913.26M | 1.76B | 1.62B |
| Gross Margin | 78.0% | 78.0% | 59.8% | 59.8% |
| Operating Margin | 18.4% | 16.6% | 16.8% | 18.7% |
| Profit Margin | 17.7% | 16.8% | 12.8% | 13.3% |
| Rev Growth | +4.1% | +4.1% | +2.8% | +18.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 1.39B | 1.39B | 5.47B | 5.57B |
| Total Equity | 24.04B | 24.04B | 37.09B | 35.00B |
| D/E Ratio | 0.06 | 0.06 | 0.15 | 0.16 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.25B | 1.14B | 3.56B | 3.45B |
| Free Cash Flow | — | — | 1.63B | 1.36B |